Professor, Division of Molecular Medicine
PhD: University of Calcutta, 1990
Visiting Faculty: Virginia Tech, USA, 1992
Post-doctoral Fellow, Cleveland Clinic, USA, 1992-1994
Visiting Scientist: Cleveland Clinic, USA, 1999-2000
Visiting Scientist: Cleveland Clinic, USA, 2002-2003
Visiting Scientist: Cleveland Clinic, USA, 2005, 2007
Visiting Scientist: Cleveland Clinic, USA, 2001-2012
o Immunotherapy of Cancer
o Tumor immune editing
o Epigenetic & transcriptional regulation of T- & B-regulatory cells development and function in cancer
o Epigenetic regulation of T cell plasticity
o Role of micro- and long non-coding in T-regulatory cell development
o Cell cycle regulation in normal and cancer cells.
o Oncogenic RAS & p53 biology
o Genomic, proteomic and system biology approach to develop targeted anti-cancer therapy
o Precision oncology
Division of Molecular Medicine
P-1/12 C.I.T. Scheme VII-M
Kolkata - 700054, India
List of Publications:
Published in Peer reviewed journals
1. Chakraborty S, Bhattacharya P, Panda AK, Kajal K & Gaurisankar Sa, & Sa, G. Clonal deletion of anti-tumorogenic IFNghiFOXP3-CD8+ Treg cells confine tumor immunosurvillance. Immunology Cell Biology. doi: 10.1111/imcb.12166. 2018
2. Chakraborty S, Panda AK, Bose S, Roy D, Kajal K, Guha D & Sa G Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells. Scientific Reports, 7, 1627, 2017
3. Saha T & Sa G. Constraint-driven docking: a logistic docking approach for deriving protein-protein complex structure. Protocol Exchange doi:10.1038/protex.2017.011, 2017
4. Panda, AK, Chakraborty, D, Sarkar, I, Khan, T & Sa, G. New insights into therapeutic activity and anticancer properties of curcumin. J. Experimental Pharmacology, 9, 31-45, 2017
5. Saha T, Guha D, Manna A, Panda AK, Bhat J, Chatterjee S, & Sa G. G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53. Scientific Reports 6, 32626; doi: 10.1038/srep32626, 2016.
6. Ray P, Guha D, Chakraborty J, Banerjee S, Adhikary A, Chakraborty S, Das T & Sa G. Crocetin exploits p53-induced death domain (PIDD) and FAS-associated death domain (FADD) proteins to induce apoptosis in colorectal cancer. Scientific Reports 6, 32979; doi: 10.1038/srep32979, 2016.
7. Bose, S, Panda AK, Mukherjee S & Sa G. Curcumin and tumor immune-editing: Resurrecting the immune system. Cell Division, 12;10:6. doi: 10.1186/s13008-015-0012-z. eCollection, 2015.
8. Saha T, Kar RK & Sa G. Structural and Sequential context of p53: A review of experimental and theoretical evidence. Progress Biophy. Mol. Biol. 117: 250-263, 2015.
9. Saha S, Bhattacharjee P, Guha D, Kajal K, Khan P, Chakraborty S, Mukherjee S, Paul S, Manchanda R, Khurana A, Nayak D, Chakrabarty R, Sa G, Das T. Sulphur alters NFκB-p300 cross-talk in favour of p53-p300 to induce apoptosis in non-small cell lung carcinoma. Int. J. Oncol. 47: 573-582, 2015.
10. Saha S, Mukherjee S, Majumder M, Manna A, Khan P, Adhikary A, Kajal K, Jana D, Sa G, Mukherjee S, Sarkar DN and Das T. Mithramycin A sensitizes therapy-resistant breast cancer stem cells towards genotoxic drug doxorubicin. Translational Res. 165: 558-577, 2015.
11. Hossain DM, Panda AK, Chakrabarty S, Bhattacharjee P, Kajal K, Mohanty S, Sarkar I, Sarkar DK, Kar SK, Sa G. MEK inhibition prevents tumor-shed TGFβ-induced T-regulatory cell augmentation in tumor milieu. Immunology 144: 561-573, 2014.
12. Chakraborty S, Das K, Saha S, Mazumdar M, Manna A, Chakraborty S, Mukherjee S, Khan P, Adhikary A, Mohanty S, Chattopadhyay S, Sa G and Das T. Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone de-acetylation. J Biol Chem. 289: 29074-29085, 2014.
13. Adhikary A, Chakraborty S, Mazumdar M, Ghosh S, Mukherjee S, Manna A, Mohanty S, Nakka KK, Joshi S, De A, Chattopadhyay S, Sa G and Das T. Inhibition of Epithelial to Mesenchymal transition by E-cadherin up-regulation via repression of Slug transcription and inhibition of E-cadherin degradation: Dual role of SMAR1 in breast cancer cells. J Biol Chem. 289: 25431-44, 2014.
14. Chakraborty S, Adhikary A, Mazumdar M, Mukherjee S, Bhattacharjee P, Guha D, Choudhuri T, Chattopadhyay S, Sa G and Das T. Capsaicin-induced activation of p53-SMAR1 auto-regulatory loop down-regulates VEGF in non-small cell lung cancer to restrain angiogenesis. PLoS ONE 9:e99743. doi: 10.1371/journal.pone.0099743, 2014.
15. Chaudhuri S, Singh MK, Bhattacharya D, Acharya S, Chatterjee S, Kumar P, Bhattacharjee P, Basu AK, Sa G, Das T, Ghosh TK, Chaudhuri S. The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation. J Neurooncol. 120:19-31. 2014.
16. Mohanty S, Saha S, Hossain DMS, Adhikary A, Mukherjee S, Manna A, Chakraborty S, Mazumdar M, Ray P, Das K, Chakraborty J, Sa G and Das T. ROS-PIASg cross-talk channelizes ATM signaling from resistance to apoptosis during chemo-sensitization of resistant tumors. Cell Death Dis. 5:e1021. doi: 10.1038/cddis.2013.534, 2014.
17. Saha S, Bhattacharjee P, Mukherjee S, Mazumdar M, Chakraborty S, Khurana A, Nayak D, Manchanda R, Chakrabarty R, Das T, Sa G. Contribution of the ROS-p53feedback loop in thuja-induced apoptosis of mammary epithelial carcinoma cells. Oncol Rep. 31:1589-98, 2014.
18. Hossain DM, Panda AK, Manna A, Mohanty S, Bhattacharjee P, Bhattacharyya S, Saha T, Chakraborty S, Kar RK, Das T, Chatterjee S, Sa G. FoxP3 acts as acotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity. 39: 1057-69, 2013
19. Mukherjee S, Ghosh S, Choudhury S, Adhikary A, Manna K, Dey S, Sa G, Das T, Chattopadhyay S. Pomegranate reverses methotrexate-induced oxidative stress and apoptosis in hepatocytes by modulating Nrf2-NFkB pathways. J Nutr Biochem 24:2040-50, doi: 10.1016/ j.jnutbio.2013.07.005, 2013.
20. Mazumdar M, Adhikary A, Chakraborty S, Mukherjee S, Manna A, Mohanty S, Ray P, Dutta A, Saha S, Chattopadhyay S, Banerjee S, Chakraborty J, Ray AK, Sa G, Das T. Targeting RET to induce medullary thyroid cancer cell apoptosis: An antagonistic interplay between PI3K/Akt/Bad pathway and death receptor-independent p38-MAPK/caspase-8 pathway. Apoptosis 18:589-604, doi: 10.1007/s10495-013-0803-0, 2013.
21. Saha S, Hossain DM, Mukherjee S, Mohanty S, Mazumdar M, Mukherjee S, Ghosh UK, Nayek C, Raveendar C, Khurana A, Chakrabarty R, Sa G, Das T. Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit. BMC Complement Altern Med. 13:230, 2013.
22. Saha B, Adhikary A, Ray P, Saha S, Chakraborty S, Mohanty S, Das K, Mukherjee S, Mazumdar M, Lahiry L, Hossain Dewan Md S, Sa G and Das T. Restoration of tumor suppressor p53 by differentially regulating pro- and anti-p53 networks in HPV-18-infected cervical cancer cells. Oncogene 31:173-86, 2012
23. Saha S, Adhikary A, Bhattacharyya P, Das T, Sa G. Death by Design: Where Curcumin Sensitizes Drug-resistant Tumours. Anticancer Res 32:2567-84, 2012.
24. Ghosh S, Adhikary A, Chakraborty S, Nandi P, Mohanty S, Chakraborty S, Bhattacharjee P, Mukherjee S, Putatunda S, Chakraborty S, Chakraborty A, Sa G, Das T and Sen PC. Nifetepimine, a dihydropyrimidone, ensures CD4+ T cell survival in tumor microenvironment by maneuvering Sarco(endo)plasmic reticulum Ca2+ATPase (SERCA). J. Biol. Chem. 287:32881-96, 2012.
25. Hossain DMS, Mohanty S, Ray P, Das T, & Sa G. Tumor gangliosides and T cells: A deadly encounter. Frontiers in Biosciences 4: 502-519, 2012.
26. Hossain DMS, Bhattacharyya S, Das T, & Sa G. Curcumin: The multi-targeted therapy for cancer regression. Frontiers in Biosciences 4: 335-355, 2012.
27. Mohanty S, Adhikary A, Chakrabarty S, Sa G & Das T. Operation ‘p53 Hunt’ to combat cancer: Theaflavins in action. Frontiers in Biosciences 4: 300-320, 2012.
28. Sen GS, Mohanty S, Hossain DM, Bhattacharyya S, Banerjee S, Chakraborty J, Saha S, Ray P, Bhattacharjee P, Mandal D, Bhattacharya A, Chattopadhyay S, Das T, Sa G. Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer. J. Biol. Chem. 286: 42232-42247, 2011.
29. Chakraborty J, Banerjee S, Ray P, Hossain DMS, Bhattacharyya S, Adhikary A, Chattopadhyay S, Das T & Sa G. Gain of cellular adaptation due to prolong p53 impairment leads to functional switch-over from p53 to p73 during DNA damage in acute myeloid leukemia cells. J. Biol. Chem. 285: 33104-33112, 2010.
30. Bhattacharyya S, Hossain D Md. S, Mohanty S, Sen GS, Chattopadhyay S, Banerjee S, Chakraborty J, Das K, Sarkar D, Das T & Sa G. (2010) Curcumin reverses T cell‐mediated adaptive immune dysfunctions in tumor‐bearing host. Cell. Mol. Immunol. 7: 306-315.
31. Lahiry L, Saha B, Chakraborty J, Adhikary A, Banerjee S, Das K, Sa G & Das T. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Carcinogenesis 31: 259-268, 2-10
32. Das T, Sa G, Saha B & Das K. Multifocal signal modulation therapy of cancer: Ancient weapon, modern targets. Mol. Cell. Biochem. 336: 85–95, 2010.
33. Sa G, Das T, Moon C, Hilston CM, Rayman PA, Rini BI, Tannenbaum CS, & Finke JH. GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells. Cancer Research. 69: 3095-3104, 2009.
34. Chattopadhyay S, Bhattacharyya S, Saha B, Chakrabarty J, Mohanty S, Hossain DMS, Banerjee S, Das K, Sa G & Das T. Tumor-shed PGE2 impairs IL2Rgc-signaling to inhibit CD4+ T cell survival: Regulation by theaflavins. PLoS One 4:e7382, 2009.
35. Chatterjee S, Mookerjee A, Mookerjee Basu J, Chakraborty P, Ganguly A, Adhikary A, Mukhopadhyay D, Banerjee R, Ashraf M, Biswas J, Das PK, Sa G, Chatterjee M, Das T & Chaudhuri SK. CuNG, a novel copper complex, modulates drug resistant tumor associated macrohages to reprogram T cells to elicit anti-tumor response. PLoS One 4:e7048, 2009.
36. Lahiry L, Saha B, Chakraborty J, Bhattacharyya S, Chattopadhyay S, Choudhuri T, Mandal D, Bhattacharyya A, Sa G & Das T. Contribution of p53-mediated transcription-dependent pathway in mammary epithelial carcinoma cell apoptosis by theaflavins. Apoptosis 13: 771-781, 2008.
37. Das T*, Sa G*, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Biswas K, Kudo D, Bukowski RM, Finke JH & Tannenbaum C. Renal Cell Carcinoma Tumors Induce T Cell Apoptosis Through Receptor-Dependent and Receptor-Independent Pathways. J. Immunol. 180: 4687-4696, 2008. [*Das T & Sa G both contributed equally]
38. Das T*, Sa G*, Hilston C, Kudo D, Rayman P, Biswas K, Molto L, Bukowski R, Rini B, Finke JH & Tannenbaum C. GM1 and TNFa, overexpressed in renal cell carcinoma, synergize to induce T cell apoptosis. Cancer Research 68: 2014-23, 2008. [*Das T & Sa G both contributed equally]
39. Sa G & Das T. Anti-cancer effects of curcumin: cycle of life and death. Cell Div. 3:14, 2008.
40. Bhattacharyya S, Mandal D, Saha B, Sen GS, Das T & Sa G. Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem. 282:15954-15964, 2007. [the paper was Press-released by American Society of Biochemistry & Molecular Biology]
41. Mandal D, Bhattacharyya S, Lahiry L, Chattopadhyay S, Sa G & Das T. Black tea-induced decrease in IL-10 and TGF-b of tumor cells promotes Th1/Tc1 response in tumor-bearer. Nutrition Cancer 58: 213-221, 2007.
42. Raval G, Biswas S, Rayman P, Biswas K, Sa G, Ghosh S, Thornton M, Hilston C, Das T, Bukowski R, Finke J & Tannenbaum CS. TNF-α Induction of GM2 Expression on Renal Cell Carcinomas Promotes T cell Dysfunction. J Immunol. 178: 6642-6522, 2007.
43. Bhattacharyya S, Mandal D, Sen GS, Pal S, Banerjee S, Lahiry L, Finke JH, Tannenbum CS, Das T & Sa G. Tumor-induced oxidative stress perturbs NFkB activity augmenting TNFa-mediated T cell death: Protection by curcumin. Cancer Research. 67: 362-370, 2007
44. Dasgupta R, Saha I, Pal S, Bhattacharyya A, Sa G, Nag TC, Das T & Maiti BR. Immunosuppression, hepatotoxicity and depression of antioxidant status by arecoline. Toxicology 227: 94-104, 2006
45. Biswas K, Richmond A , Rayman P, Biswas S, Thornton M, Sa G, Das T, Zhang R, Chahlavi A, Tannenbaum CS, Novick A, Bukowski R & Finke JH. GM2 Expression in renal cell carcinoma: Potential role in tumor-induced immune dysfunction. Cancer Research. 66: 6816-6825, 2006.
46. Mookerjee A, Mookerjee Basu J, Dutta P, Majumder S, Bhattacharyya S, Biswas J, Pal S, Mukherjee P, Raha S, Baral RN, Das T, Efferth T, Sa G, Roy S & Choudhuri SK. Overcoming drug resistant cancer by a newly developed copper chelate through host protective cytokine mediated apoptosis. Clinical Cancer Research 12: 4339-4349, 2006
47. Choudhuri T, Pal S, Das T & Sa G. (2005) Curcumin selectively induces apoptosis in deregulated cyclin D1 expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280: 20059-20068, 2005. [with front page cover citing the work]
48. Sa G, Guo Y & Stacey DW. Regulation of S phase initiation by p27Kip1 in NIH3T3 cells. Cell Cycle 4: 618-627, 2005. [with front page cover citing the work]
49. Bhattacharyya A, Lahiry L, Mandal D, Sa G & Das T. Black tea induces tumor cell apoptosis by Bax translocation, loss in mitochondrial transmembrane potential, cytochrome c release and caspase activation. Int. J. Cancer 117: 308-315, 2005.
50. Mandal D, Bhattacharyya A, Lahiry L, Bhattacharyya S, Sa G & Das T. Tumor-induced thymic involution via Inhibition of IL-7Ra and its JAK-STAT signaling pathway: Protection by Black Tea. Int. Immunopharmacol. 6: 433-444, 2005.
51. Pal S, Bhattacharya S, Choudhuri T, Datta GK, Das T & Sa G. Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin. Cancer Detection Prevention, 29: 470-478, 2005.
52. Mandal D, Bhattacharyya A, Lahiry L, Sa G & Das T. Failure in peripheral immuno-surveillance due to thymic atrophy: Importance of thymocyte maturation and apoptosis in adult tumor-bearer. Life Sci. 77: 2703-16, 2005.
53. Bandyopadhyay S, Bhattacharyya A, Mallick A, Sen AK, Tripathi G, Das T, Sa G, Bhattacharya DK & Mandal C. Over expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia. Int. Immunol. 17: 177-11, 2005.
54. Sa G & Stacey DW. P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase. Exp Cell Res 300: 427-439, 2004.
55. Bhattacharyya A, Mandal D, Lahiry L, Sa G & Das T. Black tea protects immunocytes from tumor-induced apoptosis by changing Bcl-2/Bax ratio. Cancer Lett 209: 147-154, 2004.
56. Bhattacharyya A, Chattopadhyay S, Choudhury T, Banerjee A, Sa G & Das T. Apoptogenic effects of black tea on Ehrlich's ascites carcinoma cell. Carcinogenesis 24: 75-80, 2003.
57. Sa G, Hitomi M, Harwalkar J, Stacey A, Chen G, & Stacey D. Ras is active throughout the cell cycle, but is able to induce cyclin D1 only during G2 phase. Cell Cycle 1, 50-58, 2002. [with front cover page citing the work along with a View and Commentaries (Cell Cycle 1, 36-38, 2002)]
58. Ghosh S, Bhattacharyya S, Sirkar M, Sa G, Das T, Majumdar D, Roy S & Majumdar S. Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: Involvement of extracellular signal-regulated kinase. Infect Immun 70: 6828-6838, 2002.
59. Das T, Sa G, Chattopadhyay S & Ray PK. Protein A-induced apoptosis of cancer cells is affected by soluble immune mediators. Cancer Immunology Immunotherapy 51: 376-380, 2002.
60. Choudhuri T, Pal S, Agwarwal ML, Das T & Sa G. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512: 334-340, 2002.
61. Chattopadhyay S, Das T, Sa G, & Ray PK. Protein A-activated macrophages induce apoptosis in Ehrlich's ascites carcinoma through a nitric oxide-dependent pathway. Apoptosis 7: 49-57, 2002.
62. Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T & Sa G. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochem Biophys Res Commun 288: 658-665, 2001.
63. Das T, Sa G, Subbulakshmi V, Subramaniam S, Sen PC, Biswas S & Ray PK. Protein A-activated rat spleenic lymphocyte proliferation involves tyrosine kinase - phospholipase C - protein kinase C pathway. Immunopharmacol. Immunotoxicol. 22: 75-90, 2000.
64. Ray PK, Das T, Sa G, Ghosh AK & Chattopadhyay S. Protection of apoptotic cell death by Protein A. Apoptosis 5: 509-514, 2000
65. Das T, Sa G & Ray PK. Mechanisms of Protein A superantigen-induced signal transduction for proliferation of mouse B cells. Immunol. Lett. 70: 43-51, 1999.
66. Das T, Sa G, Sinha P & Ray PK. Induction of cell proliferation and apoptosis: dependence on the dose of the inducer. Biochem. Biophys. Res. Commun. 260: 105-110, 1999.
67. Ghosh AK, Jana S, Das T, Sa G, Mondal N & Ray PK. Protection by Protein A of apoptotic death caused by anti-AIDS drug zidovudine. Biochem. Biophys. Res. Commun. 264: 601-604, 1999.
68. Sinha P, Ghosh AK, Das T, Sa G & Ray PK. Protein A of S. aureus evokes Th1 type response in mice. Immunol. Lett. 67: 157-165, 1999.
69. Sa G & Das T. Basic FGF stimulates phospholipase A2, phospholipase C-g1 and phospholipase D through distinguishable signaling mechanisms. Mol. Cell. Biochem. 198: 19-30, 1999.
70. Ghosh AK, Sinha P, Das T, Sa G & Ray PK. S. aureus superantigen Protein A expand CD4+/CD19+/ CD34+ cells in mice- a potential immunorestorer. Biochem. Biophys. Res. Commun. 256: 142-146, 1999.
71. Goenka S, Das T, Sa G & Ray PK. Protein A induces NO production: Involvement of tyrosine kinase, phospholipae C and Protein kinase C. Biochem. Biophys. Res. Commun. 250: 425-429, 1998.
72. Sa G, Murugesan G, Jaye M, Ivashenko Y & Fox PL. Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 270: 2360-2300, 1995.
73. Sa G & Fox PL. Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive phospholipase A2 activity. J Biol Chem 269:3219-3225, 1995.
74. Bandhopadhyay AK, Das T, Sa G & Mukherjea M. Relationship between glycerol 3 phosphate dehydrogenase, fatty acid synthase and FABP of developing human placenta. J Biosci 20: 141-150, 1995.
75. Fox PL, Sa G, Dobrowolski SF & Stacey DW. The regulation of endothelial cell motility by p21ras. Oncogene 9: 3519-3526, 1994.
76. Murugesan G, Sa G & Fox PL. High density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circulation Res. 74:1149-1156, 1994.
77. Sa G & Fox PL. Basic fibroblast growth factor-mediated migration and proliferation of endothelial cells are distinguished by pertussis toxin. FASEB J, 7: 1-2, 1993
78. Sa G, Das T & Mukherjea M. Characterization and binding properties of human fetal lung fatty acid binding proteins. Mol. Cell. Biochem. 129: 67-75, 1993
79. Sa G, Das T & Mukherjea M. The evaluation of lung maturity by lecithin, L/S and PG/PI ratios in human fetus. Med. Sci. Res. 21: 365-366, 1993.
80. Das T, Sa G & Mukherjea M. Characterization of cardiac fatty acid binding protein from human placenta: Comparison with placenta hepatic proteins. Eur. J. Biochem. 211: 725-730, 1993
81. Das T, Sa G, Bandhopadhyay AK & Mukherjea M. Relationship between fatty acid binding proteins, acetyl CoA formation and fatty acid synthesis in developing human placenta. J. Biosci. 16:235-242, 1991.
82. Sa G, Das T & Mukherjea M. Relationship between fatty acid synthesis, transport and total lipid content during human fetal lung development. Indian J. Biochem. Biophys. 27: 43-47, 1990
83. Sa G, Das T & Mukherjea M. Purification and characterization of fatty acid binding protein from human fetal lung. Exp. Lung Res. 15: 619-632, 1989.
84. Das T, Sa G & Mukherjea M. Human fetal liver fatty acid binding proteins. Role on glucose 6 phosphate dehydrogenase activity. Biochim. Biophys. Acta 1002: 164-172, 1989.
85. Das T, Sa G & Mukherjea M. Purification and characterization of fatty acid binding protein from developing human placenta. Lipids 23, 528-533, 1998.
86. Sa G, Das T & Mukherjea M. Ontogenic profile and properties of glucose-6-phosphate-dehydrogenase in human fetal tissues. Indian J. Biochem. Biophys. 23, 135-137, 1987.View More
- Fellow of National Academy of Science (Allahabad), 2016
- Fellow of Immunological Society of Asia-Oceania, 2015
- Fellow of West Bengal Academy of Science & Technology , 2015
- D.P. Burma Memorial Oration Award from SBC(I), 2016
- P.B. Sen Memorial Oration Award from PSI, 2015
|Dia Roy||Senior Research Fellow||Division of Molecular Medicine||Centenary||25693260||diaroy|
|Dwaipayan Chakraborty||Senior Research Fellow||Division of Molecular Medicine||Centenary||25693260|
|Saikat Dutta||Junior Research Fellow||Division of Molecular Medicine||Centenary||25693260|
|Silpita Paul||Senior Research Fellow(Extended)||Division of Molecular Medicine||Centenary||25693291|
|Subhanki Dhar||Senior Research Fellow||Division of Molecular Medicine||Centenary||25693260||subhanki.dhar|
|Sumon Mukherjee||Junior Research Fellow||Division of Molecular Medicine||Centenary||25693260|
|Tania Sarkar||Senior Research Fellow||Division of Molecular Medicine||Centenary||25693260||tania.sarkar|
Postdoctoral Fellows / RA :
|Aharna Guin||Research Associate||Division of Molecular Medicine||Centenary||25693260|